MedTrace Logo

Effects of Proxelan Somministration in Patients With Chronic Prostatitis

NCT03629769 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-08-14

No results posted yet for this study

Summary

The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.

Conditions

  • Chronic Prostatitis
  • Chronic Prostatitis With Chronic Pelvic Pain Syndrome
  • Premature Ejaculation

Interventions

DRUG

Proxelan

Administration of one suppository of proxelan once a day for 30 days

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-16
Primary Completion
2018-09-01
Completion
2018-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03629769 on ClinicalTrials.gov